Elder Pharmaceuticals is currently trading at Rs. 348.10, up by 13.90 points or 4.16% from its previous closing of Rs. 334.20 on the BSE.
The scrip opened at Rs. 337.55 and has touched a high and low of Rs. 350.90 and Rs. 337.55 respectively. So far 29188 shares were traded on the counter.
The BSE group 'B' stock of face value Rs. 10 has touched a 52 week high of Rs. 474.00 on 05-Dec-2012 and a 52 week low of Rs. 202.15 on 14-May-2013.
Last one week high and low of the scrip stood at Rs. 350.90 and Rs. 289.25 respectively. The current market cap of the company is Rs. 715.10 crore.
The promoters holding in the company stood at 39.99%, while Institutions and Non-Institutions held 23.01% and 37.00% respectively.
Elder Pharmaceuticals - wholly owned step down subsidiary - NutraHealth, the UK’s leading provider of the highest quality and innovative branded and own label vitamin and food supplements, has acquired Max Healthcare to re-enter the OTC pharmaceutical category and extend and enhance its product range. Max Healthcare will be a subsidiary of NutraHealth and will be managed in parallel with its subsidiary Brunel Healthcare Manufacturing.
Max Healthcare is an OTC business which owns a range of marketing authorizations and provides own label and branded OTC medicines and products to a broad range of customers.
Max Healthcare is predominantly an outsourced operation with most of its manufacturing taking place in India. Elder Pharmaceuticals will explore the opportunities to collaborate in the supply chain and vertical integration will be exploited wherever possible.
The scrip opened at Rs. 337.55 and has touched a high and low of Rs. 350.90 and Rs. 337.55 respectively. So far 29188 shares were traded on the counter.
The BSE group 'B' stock of face value Rs. 10 has touched a 52 week high of Rs. 474.00 on 05-Dec-2012 and a 52 week low of Rs. 202.15 on 14-May-2013.
Last one week high and low of the scrip stood at Rs. 350.90 and Rs. 289.25 respectively. The current market cap of the company is Rs. 715.10 crore.
The promoters holding in the company stood at 39.99%, while Institutions and Non-Institutions held 23.01% and 37.00% respectively.
Elder Pharmaceuticals - wholly owned step down subsidiary - NutraHealth, the UK’s leading provider of the highest quality and innovative branded and own label vitamin and food supplements, has acquired Max Healthcare to re-enter the OTC pharmaceutical category and extend and enhance its product range. Max Healthcare will be a subsidiary of NutraHealth and will be managed in parallel with its subsidiary Brunel Healthcare Manufacturing.
Max Healthcare is an OTC business which owns a range of marketing authorizations and provides own label and branded OTC medicines and products to a broad range of customers.
Max Healthcare is predominantly an outsourced operation with most of its manufacturing taking place in India. Elder Pharmaceuticals will explore the opportunities to collaborate in the supply chain and vertical integration will be exploited wherever possible.
No comments:
Post a Comment